Revenue Breakdown
Composition ()
No data
Revenue Streams
Clover Health Investments Corp (CLOV) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Insurance , accounting for 99.3% of total sales, equivalent to $353.94M. Other significant revenue streams include Corporate/Other and Eliminations. Understanding this composition is critical for investors evaluating how CLOV navigates market cycles within the Managed Healthcare industry.
Profitability & Margins
Evaluating the bottom line, Clover Health Investments Corp maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -4.91%, while the net margin is -4.91%. These profitability ratios, combined with a Return on Equity (ROE) of -16.90%, provide a clear picture of how effectively CLOV converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, CLOV competes directly with industry leaders such as CIA and PRVA. With a market capitalization of $1.20B, it holds a significant position in the sector. When comparing efficiency, CLOV's gross margin of 100.00% stands against CIA's N/A and PRVA's 10.51%. Such benchmarking helps identify whether Clover Health Investments Corp is trading at a premium or discount relative to its financial performance.
